Home
About
Overview
Sharing Data
ORCID
Help
History (9)
Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature.
Clinical analysis and pluripotent stem cells-based model reveal possible impacts of ACE2 and lung progenitor cells on infants vulnerable to COVID-19.
PUVA for cutaneous T-cell lymphoma. 10 years after.
Integrative genome modeling platform reveals essentiality of rare contact events in 3D genome organizations.
Time to tumor growth: a model end point and new metric system for oncology clinical trials.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Time to tumor growth: a model end point and new metric system for oncology clinical trials.
Time to tumor growth: a model end point and new metric system for oncology clinical trials. J Clin Oncol. 2013 Jun 10; 31(17):2070-2.
View in:
PubMed
subject areas
Antineoplastic Combined Chemotherapy Protocols
Colorectal Neoplasms
Female
Humans
Male
authors with profiles
Mark J. Ratain